 SHANGHAI, SAN FRANCISCO and CAMBRIDGE, Mass., Dec. 29, 2021 GLOBE NEWSWIRE -- Zai Lab Limited NASDAQ: ZLAB; HKEX: 9688, a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following virtual investor conferences in January: 